Project title
GALNT6在卵巢癌中改變EGFR醣基化而促進細胞惡行表徵及化療抗藥性之角色
Internal ID
MOST106-2314-B002-198
Principal Investigator
Start Date
August 1, 2017
End Date
July 12, 2018
Partner Organizations
Role of Egfr Glycosylation by Galnt6 in Enhancing Ovarian Cancer Cell Malignant Behaviors and Chemoresistance = GALNT6在卵巢癌中改變EGFR醣基化而促進細胞惡行表徵及化療抗藥性之角色
Keywords
N-乙醯半乳糖氨基轉移酶第6 型
卵巢癌
上皮生長因子接受器
醣基化
GANLT6
ovarian cancer
EGFR
glycosylation